Restoring insulin sensitivity without TZD side effects

Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease.

Annual General Meeting resolves dividend distribution of EUR 1.05 per share – Biotech Investments

EQS-News: Dermapharm Holding SE / Key word(s): AGM/EGM/Dividend Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share 14.06.2023 / 17:00

June 15, 2023

Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer – Pharmaceutical Technology

Pfizer inherited ADC Tivdak following its high-profile $43bn acquisition of Seagen in 2023. Credit: YES Market Media via Shutterstock. Pfizer and Genmab’s Tivdak (tisotumab vedotin-tftv)

April 30, 2024

New study links perfluoroalkyl substance exposure to childhood asthma phenotypes

Study evaluated the effects of exposure to perfluoroalkyl substances on asthma phenotypes.

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.